Znanstveni rad - Izvorni znanstveni rad
Safety and efficacy of fluvoxamine in COVID‐19 ICU patients: An open label, prospective cohort trial with matched controls
British Journal of Clinical Pharmacology, 88 (2022), 5; 2065-2073. https://doi.org/10.1111/bcp.15126

Čalušić, Martina; Marčec, Robert; Lukša, Lea; Jurković, Ivan; Kovač, Nataša; Mihaljević, Slobodan; Likić, Robert

Citirajte ovaj rad

Čalušić, M., Marčec, R., Lukša, L., Jurković, I., Kovač, N., Mihaljević, S. i Likić, R. (2022). Safety and efficacy of fluvoxamine in COVID‐19 ICU patients: An open label, prospective cohort trial with matched controls. British Journal of Clinical Pharmacology, 88. (5), 2065-2073. doi: 10.1111/bcp.15126

Čalušić, Martina, et al. "Safety and efficacy of fluvoxamine in COVID‐19 ICU patients: An open label, prospective cohort trial with matched controls." British Journal of Clinical Pharmacology, vol. 88, br. 5, 2022, str. 2065-2073. https://doi.org/10.1111/bcp.15126

Čalušić, Martina, Robert Marčec, Lea Lukša, Ivan Jurković, Nataša Kovač, Slobodan Mihaljević i Robert Likić. "Safety and efficacy of fluvoxamine in COVID‐19 ICU patients: An open label, prospective cohort trial with matched controls." British Journal of Clinical Pharmacology 88, br. 5 (2022): 2065-2073. https://doi.org/10.1111/bcp.15126

Čalušić, M., et al. (2022) 'Safety and efficacy of fluvoxamine in COVID‐19 ICU patients: An open label, prospective cohort trial with matched controls', British Journal of Clinical Pharmacology, 88(5), str. 2065-2073. doi: 10.1111/bcp.15126

Čalušić M, Marčec R, Lukša L, Jurković I, Kovač N, Mihaljević S, i sur.. Safety and efficacy of fluvoxamine in COVID‐19 ICU patients: An open label, prospective cohort trial with matched controls. British Journal of Clinical Pharmacology [Internet]. 05.2022. [pristupljeno 24.09.2022.];88(5):2065-2073. doi: 10.1111/bcp.15126

M. Čalušić, et al., "Safety and efficacy of fluvoxamine in COVID‐19 ICU patients: An open label, prospective cohort trial with matched controls", British Journal of Clinical Pharmacology, vol. 88, br. 5, str. 2065-2073, Svibanj 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:224631. [Citirano: 24.09.2022.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.